Wall Street is neutral on Odonate Therapeutics Inc (ODT). On average, analysts give ODT a Hold rating. The average price target is $4, which means analysts expect the stock to climb by 260.36% over the next twelve months. That average ranking earns ODT an Analyst Rating of 4, which is better than 4% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating ODT a Hold today. Find out what this means to you and get the rest of the rankings on ODT!